HI TECH PHARMACAL CO INC 4
4 · HI TECH PHARMACAL CO INC · Filed Oct 8, 2013
Insider Transaction Report
Form 4
GOLDWYN MARTIN M
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2013-10-04−1,500→ 7,875 totalExercise: $24.95From: 2006-11-08Exp: 2015-11-08→ Common Stock (1,500 underlying) - Exercise/Conversion
Common Stock
2013-10-04$24.95/sh+1,500$37,425→ 1,500 total - Sale
Common Stock
2013-10-04$43.10/sh−1,500$64,650→ 0 total
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.08 to $43.16, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) of this Form 4.
- [F2]Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 1994 Directors Stock Option Plan.
- [F3]The option became exercisable in four equal annual installments beginning on the first anniversary of the grant date.
- [F4]Other than the option to acquire an additional 9,375 shares of the Company's stock reflected on this form as still held by the filer, the filer is also the holder of additional options to acquire 75,400 shares of the Company's stock (for options to acquire an aggregate of 84,775 shares). The other options were granted on various dates, with varying exercise prices and exercisable and expiration dates.